Cardiac risk stratification is a critical process in assessing an individual's likelihood of developing cardiovascular complications and tailoring appropriate preventive measures. This method involves the systematic evaluation of various risk factors that contribute to heart-related issues, such as age, gender, family history, smoking habits, blood pressure, cholesterol levels, and existing medical conditions. By analyzing these factors, healthcare professionals can categorize individuals into different risk groups, ranging from low to high risk. This stratification enables the development of personalized intervention plans, including lifestyle modifications, medication, and regular monitoring, to mitigate the potential for cardiac events. Accurate risk assessment is instrumental in enhancing early detection and intervention, ultimately improving patient outcomes and reducing the overall burden of cardiovascular diseases. Regular updates to risk stratification guidelines ensure that healthcare providers stay abreast of the latest research and technological advancements, refining their ability to predict and manage cardiac risks effectively.
Title : Surgical options for aortic valve preservation
John R Doty, Intermountain Medical Center, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Doppler ultrasound measurement of central artery elasticity: A new natural-frequency framework for cardiovascular risk assessment
Trevor Tucker, Dynamic Vascular Resolution Inc., Canada
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain